In the last eight years, geneticists have figured out how to edit humanity’s genetic code by harnessing a natural phenomenon known as CRISPR. This innovation has the potential to let us cure horrible genetic diseases, and perhaps augment humanity even further. But this also raises the ethical question: How far should genome editing go, if it’s permitted at all? On today’s episode, I speak with Kevin Davies about the new practical capabilities and ethical questions of this new era of genome editing.

Kevin is the executive editor of The CRISPR Journal and the founding editor of Nature Genetics. He is also the author of several books, including “Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing,” which will be out in the first week of October. Kevin, welcome to the podcast.

The post Kevin Davies: Genome editing and the CRISPR revolution appeared first on American Enterprise Institute – AEI.

Subscribe to Political Economy with James Pethokoukis in Apple Podcasts (and leave a 5-star review, please!), or by RSS feed. For all our podcasts in one place, subscribe to the Ricochet Audio Network Superfeed in Apple Podcasts or by RSS feed.